---
title: "Viking Global Opportunities GP LLC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95
json: https://whiteintel.dev/api/public/dossier/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95
identifier: sec:0001629476
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Viking Global Opportunities GP LLC

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001629476`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95  

## Ownership & control

### Holdings / subsidiaries

- **ACUREN CORP** (10% owner) — https://whiteintel.dev/entity/fec26ad0-8824-5284-9b3a-590e848a01f7
- **BridgeBio Pharma, Inc.** (10% owner) — https://whiteintel.dev/entity/88635c8c-0adf-560a-a3ee-e2e0ebab90a9
- **Inhibrx Biosciences, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7b8e82d8-d39e-5ead-a3a9-a9d05add29f2
- **BridgeBio Pharma, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/88635c8c-0adf-560a-a3ee-e2e0ebab90a9
- **ACUREN CORP** (tenpercentowner) — https://whiteintel.dev/entity/fec26ad0-8824-5284-9b3a-590e848a01f7
- **INHIBRX, INC.** (tenpercentowner) — https://whiteintel.dev/entity/62e13d0e-da89-5e71-9906-18ec7f5f7f52
- **APi Group Corp** (tenpercentowner) — https://whiteintel.dev/entity/44e3b05f-3b5b-5886-8cb5-56017f5fa0c0
- **STANDARD BIOTOOLS INC.** (tenpercentowner) — https://whiteintel.dev/entity/4320d5d4-7b2b-5d02-939a-761afe0346c0
- **4D Molecular Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/d72c9d0a-737e-53ec-b488-9dc05920e9a3
- **RAYZEBIO, INC.** (tenpercentowner) — https://whiteintel.dev/entity/84c3a732-6df0-59c0-9df6-adef1b5b6dcf
- **Roivant Sciences Ltd.** (tenpercentowner) — https://whiteintel.dev/entity/9910ff0b-1338-5e52-b86d-598f5d80a098
- **Rallybio Corp** (tenpercentowner) — https://whiteintel.dev/entity/dea82766-1928-555e-ae39-e27b264fd1ca
- **FRAZIER LIFESCIENCES ACQUISITION CORP** (tenpercentowner) — https://whiteintel.dev/entity/9bc17048-c8b1-54d6-ac0a-525a34f190f0
- **Amylyx Pharmaceuticals, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/9406e386-c399-56ce-9f78-0b28d2649efb
- **Ginkgo Bioworks Holdings, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/dc13e473-5366-53b5-8e8c-fb61ca632a0e
- **PROCEPT BioRobotics Corp** (tenpercentowner) — https://whiteintel.dev/entity/7b621eb4-664b-548b-9092-82ce58917145
- **FIGS, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/4bf0eff5-3631-5680-b98f-2a490de23f6d
- **Adaptive Biotechnologies Corp** (tenpercentowner) — https://whiteintel.dev/entity/0cab6689-48d6-5c9f-9794-76e738b35449
- **Zentalis Pharmaceuticals, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/9afb0ed4-db40-5db3-b5b3-1b855d838e07
- **UROVANT SCIENCES LTD.** (other) — https://whiteintel.dev/entity/0c95e3a3-5d2c-51c3-a3be-3813631b441e
- **MYOVANT SCIENCES LTD.** (other) — https://whiteintel.dev/entity/2dddc89f-1bb7-51f0-a601-6d212dd476de
- **Arbutus Biopharma Corp** (other) — https://whiteintel.dev/entity/2877a2b1-900f-5861-a06c-9f05f016257a
- **AXOVANT GENE THERAPIES LTD.** (other) — https://whiteintel.dev/entity/6d8e552c-7ff4-5297-898e-71a2118f72f1
- **UROVANT SCIENCES LTD.** (tenpercentowner) — https://whiteintel.dev/entity/0c95e3a3-5d2c-51c3-a3be-3813631b441e
- **MYOVANT SCIENCES LTD.** (tenpercentowner) — https://whiteintel.dev/entity/2dddc89f-1bb7-51f0-a601-6d212dd476de
- **AXOVANT GENE THERAPIES LTD.** (tenpercentowner) — https://whiteintel.dev/entity/6d8e552c-7ff4-5297-898e-71a2118f72f1
- **Arbutus Biopharma Corp** (tenpercentowner) — https://whiteintel.dev/entity/2877a2b1-900f-5861-a06c-9f05f016257a
- **Editas Medicine, Inc.** (other) — https://whiteintel.dev/entity/ef77060a-ecdc-5822-8634-7ef724c01154
- **Editas Medicine, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/ef77060a-ecdc-5822-8634-7ef724c01154

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Viking Global Opportunities GP LLC**. Human view: https://whiteintel.dev/entity/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95 · Structured JSON: https://whiteintel.dev/api/public/dossier/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._